» Factor VIII Inhibitor Weak Control

ROUTINE INHIBITOR ASSAYS FACTOR VIII INHIBITOR CONTROLS

Factor VIII Inhibitor Weak Control

Chronometric assay

Factor VIII deficient plasma pool containing an anti-FVIII inhibitor.

Factor VIII Inhibitor Weak Control plasma is a frozen human plasma, native hemophilia A, guaranteed with a natural inhibitor directed against FVIII and having FVIII activity <1%.
All other coagulation factors have normal hemostasis values.
The titer expressed in BU is indicated on each box.

Your opinion on this product ?

Reference	Presentation	Packaging
6-1800-05	Vial	25 x 0.5 mL

The Safety Data Sheets and Notices are accessible to our registered customers.

Treatment for hemophilia A consists of injecting the missing factor VIII I.V. to prevent or stop bleeding. A majority of the complications of this treatment are the development of antibodies against FVIII, called inhibitors.
The development of an anti-FVIII inhibitor leads to episodes of bleeding that are difficult to control.
The activity of the inhibitor is measured by a Bethesda test and is expressed in BU.
1BU neutralizes 50% of the activity of FVIII for hemophilia A.

Control titrated to the cut-off value according to HAS recommendations.

The stability of the product is 7 days at -20 °C.
Bethesda Unit title depending on lots and tests (close to 1.5 Bethesda Unit).

25 cryotubes x 0.5 mL of frozen plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.

ROUTINE INHIBITOR ASSAYS FACTOR VIII INHIBITOR CONTROLS

Factor VIII Inhibitor Weak Control

Chronometric assay

Your opinion on this product ?

The Safety Data Sheets and Notices are accessible to our registered customers.

Cryopep Thrombosis Haemostasis Catalogue 2022

Cryopep Haemostasis Research Catalogue 2022

You must identify yourself to search for a certificate of analysis

ROUTINE INHIBITOR ASSAYS FACTOR VIII INHIBITOR CONTROLS

Factor VIII Inhibitor Weak Control

Chronometric assay

Download the catalog brochure

Your opinion on this product ?

The Safety Data Sheets and Notices are accessible to our registered customers.

Cryopep Thrombosis Haemostasis Catalogue 2022

Cryopep Haemostasis Research Catalogue 2022